Form 8-K - Current report:
SEC Accession No. 0001493152-24-014446
Filing Date
2024-04-12
Accepted
2024-04-12 16:05:40
Documents
13
Period of Report
2024-04-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 35234
  Complete submission text file 0001493152-24-014446.txt   209732

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE telo-20240412.xsd EX-101.SCH 3030
3 XBRL LABEL FILE telo-20240412_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE telo-20240412_pre.xml EX-101.PRE 22369
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3768
Mailing Address 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606
Business Address 900 WEST PLATT STREET, SUITE 200 TAMPA FL 33606 (813) 864-2562
Telomir Pharmaceuticals, Inc. (Filer) CIK: 0001971532 (see all company filings)

EIN.: 872606031 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41952 | Film No.: 24841451
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)